Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Identifying lethal lung cancers from non-lethal disease using CT and pathology image markers

Principal Investigator
Name
Peng Huang
Degrees
Ph.D
Institution
Johns Hopkins University
Position Title
Associate Professor of Oncology and Biostatistics
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
2017-9001
Initial CDAS Request Approval
Sep 20, 2017
Title
Identifying lethal lung cancers from non-lethal disease using CT and pathology image markers
Summary
This project will create high resolution H&E images from the National Lung Screening Trial (NLST) H&E slides using hyperspectral slide scanning system, and to create second harmonic generation microscopy scans from a subset of these slides using multiphoton Olympus microscope. The objective is to extract features from CT images, H&E images, and microspcopy collagen 1 fibers by recognizing various lung abnormality patterns. Machine learning will be used to develop diagnostic algorithms to predict lung cancer progression. Several risk scores will be developed to help clinicians to determine who needs aggressive treatment and who can be followed conservatively. Images generated from this project will be made available to lung cancer research communities.
Aims

Aim 1. To extract features from CT images, H&E pathology images, and microspcopy images, and to identify markers that are associated with overall survival.

Aim 2. To develop risk scores to identify lethal lung cancers from non-lethal disease by combining markers from aim 1 and epidemiology risk factors.

Aim 3. To determine differences in collagen 1 fiber patterns in lung cancer patients with poor survival and prolonged survival, and to test if the addition of collagen 1 fiber features could increase the prediction accuracy.

Collaborators

Peng Huang (Johns Hopkins University)
Calum MacAulay (British Columbia Cancer Agency)
Pei-Hsun Wu (Johns Hopkins University)
Zaver M. Bhujwalla (Johns Hopkins University)
Kristine Glunde (Johns Hopkins University)
Peter B. Illei (Johns Hopkins University)